Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms
Background: Cardiovascular disease (CVD) risk-prediction algorithms are key in determining one’s eligibility for prevention strategies, but are often population-specific. Metabolic syndrome (MetS), a clustering of risk factors that increase the risk of CVD, does not currently have a risk-prediction...
| Main Authors: | Zomer, E., Liew, D., Owen, A., Magliano, D., Ademi, Z., Reid, Christopher |
|---|---|
| Format: | Journal Article |
| Published: |
2014
|
| Online Access: | http://hdl.handle.net/20.500.11937/23405 |
Similar Items
Validation of two Framingham cardiovascular risk prediction algorithms in an Australian population: The 'old' versus the 'new' Framingham equation
by: Zomer, E., et al.
Published: (2011)
by: Zomer, E., et al.
Published: (2011)
Predicting the impact of polypill use in a metabolic syndrome population: An effectiveness and cost-effectiveness analysis
by: Zomer, E., et al.
Published: (2013)
by: Zomer, E., et al.
Published: (2013)
More or less physical activity and the effect on cardiovascular mortality in a high-risk population
by: Zomer, E., et al.
Published: (2011)
by: Zomer, E., et al.
Published: (2011)
Statins for people at low risk of cardiovascular disease: Authors' reply
by: Zomer, E., et al.
Published: (2012)
by: Zomer, E., et al.
Published: (2012)
The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: Best case scenario analysis using a Markov model
by: Zomer, E., et al.
Published: (2012)
by: Zomer, E., et al.
Published: (2012)
Central Obesity and Multivariable Cardiovascular Risk as Assessed by the Framingham Prediction Scores
by: Dhaliwal, Satvinder, et al.
Published: (2009)
by: Dhaliwal, Satvinder, et al.
Published: (2009)
Serum Alanine Aminotransferase, Metabolic Syndrome, and Cardiovascular Disease in an Australian Population
by: Olynyk, John, et al.
Published: (2008)
by: Olynyk, John, et al.
Published: (2008)
Validation of the framingham general cardiovascular risk score in a multi-ethnic Asian population a retrospective cohort study
by: Chia, Yook Chin, et al.
Published: (2015)
by: Chia, Yook Chin, et al.
Published: (2015)
Outcomes and excess costs among patients with cardiovascular disease
by: Ademi, Z., et al.
Published: (2013)
by: Ademi, Z., et al.
Published: (2013)
The mediating role of metabolic syndrome in cardiovascular diseases
by: Noryanti, Muhammad, et al.
Published: (2019)
by: Noryanti, Muhammad, et al.
Published: (2019)
Association of ABO blood group and leptin level on Framingham risk score in determining cardiovascular disease risk
by: Md Noor, Sabariah, et al.
Published: (2024)
by: Md Noor, Sabariah, et al.
Published: (2024)
The metabolic syndrome and cancer: Is the metabolic syndrome useful for predicting cancer risk above and beyond its individual components?
by: Harding, J., et al.
Published: (2015)
by: Harding, J., et al.
Published: (2015)
Review on Cardiovascular Risk Prediction
by: Ruwanpathirana, T., et al.
Published: (2015)
by: Ruwanpathirana, T., et al.
Published: (2015)
Epidemiology of cardiovascular disease
by: Reid, Christopher, et al.
Published: (2016)
by: Reid, Christopher, et al.
Published: (2016)
Prevention of Cardiovascular Disease
by: Owen, A., et al.
Published: (2012)
by: Owen, A., et al.
Published: (2012)
DEVELOPMENT OF A CARDIOVASCULAR MORTALITY RISK PREDICTION MODEL FOR PARTICIPANTS IN THE OHASAMA STUDY
by: Huq, M., et al.
Published: (2014)
by: Huq, M., et al.
Published: (2014)
Risk factor management in a contemporary Australian population at increased cardiovascular disease risk
by: Campbell, D., et al.
Published: (2018)
by: Campbell, D., et al.
Published: (2018)
Independent external validation of cardiovascular disease mortality in women utilising Framingham and SCORE risk models: a mortality follow-up study
by: Goh, Louise, et al.
Published: (2014)
by: Goh, Louise, et al.
Published: (2014)
Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective
by: Zomer, E., et al.
Published: (2018)
by: Zomer, E., et al.
Published: (2018)
Comparisons of metabolic syndrome definitions in four populations of the Asia-Pacific region
by: Lee, Crystal, et al.
Published: (2008)
by: Lee, Crystal, et al.
Published: (2008)
Can oral vitamin D prevent the cardiovascular diseases among migrants in Australia? Provider perspective using Markov modelling
by: Ruwanpathirana, T., et al.
Published: (2015)
by: Ruwanpathirana, T., et al.
Published: (2015)
Drug treatment and cost of cardiovascular disease in Australia
by: Ademi, Z., et al.
Published: (2009)
by: Ademi, Z., et al.
Published: (2009)
Metabolic Syndrome
by: Hill, Kylie
Published: (2014)
by: Hill, Kylie
Published: (2014)
Overview of pharmacoeconomic modelling methods
by: Ademi, Z., et al.
Published: (2013)
by: Ademi, Z., et al.
Published: (2013)
Population screening an important step in identifying and increasing awareness of cardiovascular disease in developing countries
by: Davidson, P., et al.
Published: (2012)
by: Davidson, P., et al.
Published: (2012)
Probability of cardiovascular disease and
assessing the relationship of job stress on
cvd risk: a study among primary
healthcare providers in Kelantan using
the Framingham and Globorisk scores
by: Aziz, Wira Alfatah Ab Ayah @ Ab
Published: (2020)
by: Aziz, Wira Alfatah Ab Ayah @ Ab
Published: (2020)
Metabolic syndrome in Iran
by: Berenjy, Shila, et al.
Published: (2010)
by: Berenjy, Shila, et al.
Published: (2010)
Prehypertensive state, mild hypertension, metabolic
syndrome and cardiovascular risk factors among
young adults in rural Malaysia
by: Abdullah, Aszrin, et al.
Published: (2018)
by: Abdullah, Aszrin, et al.
Published: (2018)
Assessment of vitamin D and its association with cardiovascular disease risk factors in an adult migrant population: An audit of patient records at a Community Health Centre in Kensington, Melbourne, Australia
by: Ruwanpathirana, T., et al.
Published: (2014)
by: Ruwanpathirana, T., et al.
Published: (2014)
Blood lipids and the incidence of atrial fibrillation: The multi-ethnic study of atherosclerosis and the framingham heart study
by: Alonso, A., et al.
Published: (2014)
by: Alonso, A., et al.
Published: (2014)
Correlation between framingham risk score and cardiometabolic risk profile in Malaysian obese adults
by: Shahadan, Siti Zuhaidah, et al.
Published: (2016)
by: Shahadan, Siti Zuhaidah, et al.
Published: (2016)
Associations of public transport accessibility with walking, obesity, metabolic syndrome and diabetes
by: Barr, A., et al.
Published: (2016)
by: Barr, A., et al.
Published: (2016)
Comparison of predictive performance of renal function estimation equations for all-cause and cardiovascular mortality in an elderly hypertensive population
by: Chowdhury, E., et al.
Published: (2015)
by: Chowdhury, E., et al.
Published: (2015)
Metabolic syndrome and risk of cardiovascular disease in apparently healthy Pakistani adults: a comparative study of different diagnostic criteria
by: Adil, Syed Omair
Published: (2024)
by: Adil, Syed Omair
Published: (2024)
Metabolic syndrome: Where it all begins
by: Khalid, AK
Published: (2011)
by: Khalid, AK
Published: (2011)
Asthma and Metabolic Syndrome - Where is the Link?
by: Ibrahim, Baharudin, et al.
Published: (2016)
by: Ibrahim, Baharudin, et al.
Published: (2016)
The metabolic syndrome: an overview and proposed mechanisms
by: Thomaz, Fernanda Santos, et al.
Published: (2024)
by: Thomaz, Fernanda Santos, et al.
Published: (2024)
Prediction of cardiovascular and all-cause mortality at 10 years in the hypertensive aged population
by: Huynh, Q., et al.
Published: (2015)
by: Huynh, Q., et al.
Published: (2015)
Inertia or inaction? blood pressure management and cardiovascular risk in diabetes
by: Owen, A., et al.
Published: (2009)
by: Owen, A., et al.
Published: (2009)
Home-based lifestyle intervention for rural adults improves metabolic syndrome parameters and cardiovascular risk factors: A randomised controlled trial.
by: Blackford, Krysten, et al.
Published: (2016)
by: Blackford, Krysten, et al.
Published: (2016)
Similar Items
-
Validation of two Framingham cardiovascular risk prediction algorithms in an Australian population: The 'old' versus the 'new' Framingham equation
by: Zomer, E., et al.
Published: (2011) -
Predicting the impact of polypill use in a metabolic syndrome population: An effectiveness and cost-effectiveness analysis
by: Zomer, E., et al.
Published: (2013) -
More or less physical activity and the effect on cardiovascular mortality in a high-risk population
by: Zomer, E., et al.
Published: (2011) -
Statins for people at low risk of cardiovascular disease: Authors' reply
by: Zomer, E., et al.
Published: (2012) -
The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: Best case scenario analysis using a Markov model
by: Zomer, E., et al.
Published: (2012)